What Was Behind Tesaro Inc.'s 21% Pop?
Tesaro and Opko's rolapitant successfully achieved primary and secondary endpoints in reducing chemotherapy-induced nausea and vomiting.
Why TESARO, Kandi Technologies, and Pinnacle Foods Are Today's 3 Best Stocks
Investors' appetite for risk pushed the S&P 500 to a new record close, while TESARO, Kandi Technologies, and Pinnacle Foods all surged higher by double-digit percentages.
Monday’s Top Health Care Stories: Tesaro, Alnylam, Allergan, and Valeant
Tesaro, Alnylam, Allergan, and Valeant could make waves across the health-care sector this morning.
Biotech of the Week: Opko Health Inc.
Opko Health competes with Laboratory Corporation of America and Quest Diagnostics on the diagnostics side and is partnered with Tesaro on the therapeutics side.